Learn more about how FUJIFILM Biotechnologies can accelerate the delivery of manufacturing capacity using the kojoX™ ecosystem.

Learn more about ShunzymeX™, a precision purification platform with a novel scarless protease that accelerates the path to GMP for complex biologics.

Paveway™ PLUS is a proven technology for microbial strain selection that helps you to make better informed decisions and accelerate entry to GMP.

Read up on FUJIFILM Biotechnologies' February 2026 Special Edition of the IN FOCUS Newsletter.

Following the clinical and commercial success of monoclonal antibodies, Fc-based therapies have captured substantial attention in the biopharmaceutical industry; however, their inherent complexity continues to…

Read up on FUJIFILM Biotechnologies' January 2026 Special Edition of the IN FOCUS Newsletter.

Amid rising tariff pressures and shifting global policies, biopharma manufacturers are rethinking where and how therapies are produced. As companies...

FUJIFILM Biotechnologies’ integrated ecosystem unites single-use and stainless-steel manufacturing to deliver faster, flexible, sustainable biologics.

Learn about how our formulation development team works to help bring life-saving therapeutics to patients no matter your molecule’s specific needs.

Learn about how FUJIFILM Biotechnologies supports clients from early process development to commercial readiness in our recent webinar.